These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36185276)

  • 21. Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells.
    Bian J; He L; Wu Y; Liu W; Ma H; Sun M; Yu J; Yu Z; Wei M
    Life Sci; 2020 Apr; 246():117396. PubMed ID: 32035130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
    Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A
    Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.
    Guo Y; Li Z; Parsels LA; Wang Z; Parsels JD; Dalvi A; The S; Hu N; Valvo VM; Doherty R; Peterson E; Wang X; Venkataraman S; Agnihotri S; Venneti S; Wahl DR; Green MD; Lawrence TS; Koschmann C; Morgan MA; Zhang Q
    bioRxiv; 2024 Aug; ():. PubMed ID: 39253432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression.
    Greene TT; Tokuyama M; Knudsen GM; Kunz M; Lin J; Greninger AL; DeFilippis VR; DeRisi JL; Raulet DH; Coscoy L
    Elife; 2016 Nov; 5():. PubMed ID: 27874833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.
    Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC
    Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma.
    Lu X; Liu M; Yang J; Que Y; Zhang X
    Clin Exp Immunol; 2022 Aug; 209(2):127-139. PubMed ID: 35867577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
    Diermayr S; Himmelreich H; Durovic B; Mathys-Schneeberger A; Siegler U; Langenkamp U; Hofsteenge J; Gratwohl A; Tichelli A; Paluszewska M; Wiktor-Jedrzejczak W; Kalberer CP; Wodnar-Filipowicz A
    Blood; 2008 Feb; 111(3):1428-36. PubMed ID: 17993609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diterpenoid adenanthin upregulates the expression of natural killer group 2D receptor ligands in hepatocellular carcinoma cells.
    Zhong X; Liao H; Hu S; Luo K; Zhu H
    Mol Cell Probes; 2021 Oct; 59():101759. PubMed ID: 34265372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
    Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack.
    Vinnars MT; Björk E; Nagaev I; Ottander U; Bremme K; Holmlund U; Sverremark-Ekström E; Mincheva-Nilsson L
    Am J Reprod Immunol; 2018 Jul; 80(1):e12969. PubMed ID: 29741244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis.
    Amin PJ; Shankar BS
    Life Sci; 2015 Apr; 126():19-27. PubMed ID: 25721293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu L; Sun L; Liu X; Wang X; Yan H; Pu Q; Xie Y; Jiang Y; Du J; Yang Z
    Hepatol Res; 2023 May; 53(5):417-431. PubMed ID: 36628564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO
    Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation.
    Hsu WC; Ramesh S; Shibu MA; Chen MC; Wang TF; Day CH; Chen RJ; Padma VV; Li CC; Tseng YC; Huang CY
    Phytomedicine; 2021 Feb; 82():153442. PubMed ID: 33412494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.